Therapy Areas: Diabetes
BING Innovations declares launch of DigiVibe cordless handheld device for blood glucose monitoring
1 November 2021 -

Health technology company BING Innovations LLC on Monday declared the launch of DigiVibe, cordless handheld device for blood glucose monitoring that uses vibration technology to improve the ease of diabetes management.

DigiVibe applies vibration directly to the finger. The device blocks pain signals to the brain and helps to make the process more tolerable for both children and adults.

According to the company, Digivibe is an FDA-registered and CE-certified device that was designed in the US and is manufactured in Mexico. The portable device is easy to use and adheres to any flat surface for hands-free use. This makes self-testing and diabetes management easier and more convenient.

Dr Marcelo Bendix, Endocrinologist and DigiVibe Medical Advisor, stated: "Pain and finger soreness are among the top reasons diabetics sometimes skip blood glucose testing, which is not only dangerous, but makes it quite difficult for them to effectively manage diabetes. DigiVibe is truly a game-changer; it will allow patients to stay on top of their glucose testing and no longer fear the dreaded finger-prick they have to endure in the doctor's office and at home."

The DigiVibe Starter Kit retails for USD119.00. It includes a sleek carrying case containing one DigiVibe device, stand and tip, lancing device, five 30-gauge lancets, and one AA lithium battery. The battery is designed to last for approximately three months or roughly 450 finger sticks for a single user.



Related Headlines